Jeffrey L. Rutherford - 08 Mar 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP and CFO
Signature
Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Issuer symbol
DBD
Transactions as of
08 Mar 2022
Net transactions value
$0
Form type
4
Filing time
10 Mar 2022, 15:29:32 UTC
Previous filing
08 Feb 2022
Next filing
12 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Award $0 +185,383 +81% $0.000000 413,143 08 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 68,572 08 Mar 2022 Common Shares 68,572 $4.08 Direct F3
holding DBD Non-Qualified Stock Option 18,898 08 Mar 2022 Common Shares 18,898 $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes restricted stock units.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.